Bulletins - Pregnancy/Breastfeeding
Filter by category:
AdministrationAdverse drug reactionsCannabis-based productsComplementary and Alternative Medicines (CAMs)Drug comparisonsExtremes of Age – paediatric and elderlyInteractionsNew medicineOtherPharmacokineticPregnancy/Breastfeeding


Metronidazole in Pregnancy and Breastfeeding - August 27, 2020
Metronidazole in Pregnancy and Breastfeeding
There is inconsistent advice regarding the use of metronidazole in pregnant and breastfeeding women. Historically, its safety in pregnancy and breastfeeding has been controversial due to data from animal studies showing that metronidazole is potential...



Antidepressants and Breastfeeding - October 4, 2019
Infant exposure to antidepressants via breast milk is generally low. Post-natal depression affects 10-15% of women and is often treated with antidepressants. The benefits of breastfeeding, and treating depression, usually outweigh any theoretical risk to the infant posed by antidepressants. It is...



Treatment of Allergic Rhinitis in Pregnancy and Breastfeeding - May 30, 2019
Allergic rhinitis is characterised by symptoms such as sneezing, a runny, itchy or blocked nose and itchy, watery eyes. It is very common, affecting up to 30% of the adult population. People with seasonal rhinitis ("hay fever") exhibit symptoms at specific times of the year (usually spring and su...



Neuropathic pain in pregnancy: gabapentinoids & antiepileptic dugs - July 1, 2018
When treating neuropathic pain in a woman who is pregnant, the use of gabapentinoids (e.g. gabapentin) or an antiepileptic drug (AED) (e.g. levetiracetam, lamotrigine) is a last line option. This is due to the limited availability of data for safe use during pregnancy. Other options should be tri...



Antidepressant use in pregnancy – part 2 - April 1, 2017
Depression affects approximately 10% of pregnant women and is associated with adverse maternal and foetal outcomes. The decision to use or continue antidepressants in pregnancy centres around the risks to the mother and baby of untreated maternal depression, the effectiveness of non-pharmacologic...



Antidepressant use in pregnancy – part 1 - April 1, 2017
Depression affects approximately 10% of pregnant women and can be associated with adverse maternal and foetal outcomes. The decision to use or continue antidepressants in pregnancy centres around the risks to the mother and baby of untreated maternal depression, the effectiveness of non-pharmacol...



Treatment of nausea and vomiting during pregnancy - September 1, 2016
Background
Nausea and vomiting are experienced by up to 80% of pregnant women. This is often referred to as morning sickness, although nausea and vomiting may occur at other times of the day. For the majority of pregnant women these symptoms are limited to the first trimester and are manageable,...